The girl, who was born in April and is being referred to as the "Los Angeles baby," remains on three standard HIV medications. Because of this, doctors cannot say for certain yet whether the infant is cured or whether the disease has gone into remission.
06 March 2014 | Los Angeles Times
Key changes made by the Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (the Panel) to update the November 1, 2012, Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection are summarized below.
17 February 2014 | AIDSinfo
Nearly half of HIV-infected teenagers and young adults forego timely treatment, delaying care until their disease has advanced, which puts them at risk for dangerous infections and long-term complications, according to a study led by the Johns Hopkins Children's Center.
04 February 2014 | Eurekalert Inf Dis
The oral suspension may be used in patients as young as four weeks of age, weighing at least 3 kg to less than 20 kg. The safety and efficacy of ISENTRESS have not been established in infants less than four weeks of age. Formulations of ISENTRESS for specific populations now include oral suspension, chewable tablets and film-coated tablets.
09 January 2014 | Wall Street Journal
Through this program, Janssen will donate its HIV medicines PREZISTA® (darunavir) and INTELENCE® (etravirine), including child-friendly formulations, free of charge to eligible countries with the clinical capacity and willingness to address second- and third-line pediatric HIV treatment. Each child enrolled will receive Janssen’s donated HIV medicines as needed until they turn 19 at which point they will be transitioned into the adult national HIV program or other designated by the national HIV program for continued treatment.
10 December 2013 | Johnson & Johnson press release
More than a quarter of a million children each year are born infected with the virus that causes AIDS, but too few are being tested early to receive treatment and prolong their lives, the United Nations said on Wednesday. Michele Sidibe, executive director of UNAIDS, called for diagnostic kits to be improved for detection in babies of the Human Immunodeficiency Virus (HIV) that causes AIDS, and for their "still high" current price of $25-50 to be brought down.
20 November 2013 | Reuters
Although younger children with HIV are at high risk of disease progression if not treated, new research published this week in PLOS Medicine indicates that they have good potential for achieving high CD4 counts in later life provided antiretroviral therapy (ART) is initiated according to current treatment guidelines. However, the research also suggests that the recommended CD4 count thresholds for ART initiation are unlikely to maximize immunological health in children who have never received ART before the age of ten years.
30 October 2013 | EurekAlert
World closing in on Millennium Development Goal 6, globally the AIDS epidemic has been halted and reversed—race is on to reach universal access to HIV treatment.
23 September 2013 | UNAIDS
A landmark five-year trial has strengthened evidence that early use of antiretroviral drugs helps children combat the AIDS virus, doctors reported on Thursday.
22 August 2013 | FRANCE 24
The trial of a 28-year-old man from Zezani in Beitbridge who was arrested for fatally assaulting his 12-year-old brother for refusing to take his anti-retroviral tablets has been postponed to August 30.
21 August 2013 | AllAfrica